{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:31:45Z","timestamp":1793316705834,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.celrep.2015.12.003","type":"journal-article","created":{"date-parts":[[2015,12,18]],"date-time":"2015-12-18T17:08:47Z","timestamp":1450458527000},"page":"2715-2727","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":142,"title":["MLL-Rearranged Acute Lymphoblastic Leukemias Activate BCL-2 through H3K79 Methylation and Are Sensitive to the BCL-2-Specific Antagonist ABT-199"],"prefix":"10.1016","volume":"13","author":[{"given":"Juliana\u00a0M.","family":"Benito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Godfrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Hogdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Wunderlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Marzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine\u00a0G.","family":"Harutyunyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Golfman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"North","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Kerry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Ballabio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Triona\u00a0N\u00ed","family":"Chonghaile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Gonzalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihua","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irmela","family":"Jeremias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LaKiesha","family":"Debose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Jacamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin\u00a0R.","family":"Coombes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nianxiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah\u00a0A.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagop\u00a0M.","family":"Kantarjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel\u00a0D.","family":"Leverson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven\u00a0M.","family":"Kornblau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Andreeff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"M\u00fcschen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick\u00a0A.","family":"Zweidler-McKay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James\u00a0C.","family":"Mulloy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Letai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas\u00a0A.","family":"Milne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Konopleva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2015.12.003_bib1","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1158\/0008-5472.CAN-14-1849","article-title":"BH3 inhibitor sensitivity and Bcl-2 dependence in primary acute lymphoblastic leukemia cells","volume":"75","author":"Alford","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2015.12.003_bib2","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ng.3230","article-title":"The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias","volume":"47","author":"Andersson","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.celrep.2015.12.003_bib3","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1182\/blood-2014-01-547695","article-title":"Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia","volume":"123","author":"Beldjord","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2015.12.003_bib4","doi-asserted-by":"crossref","first-page":"15751","DOI":"10.1073\/pnas.1111498108","article-title":"Function of leukemogenic mixed lineage leukemia 1 (MLL) fusion proteins through distinct partner protein complexes","volume":"108","author":"Biswas","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2015.12.003_bib5","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1182\/blood-2009-06-229542","article-title":"The AF4.MLL fusion protein is capable of inducing ALL in mice without requirement of MLL.AF4","volume":"115","author":"Bursen","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2015.12.003_bib6","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ccr.2006.03.027","article-title":"Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members","volume":"9","author":"Certo","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2015.12.003_bib7","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1158\/1535-7163.MCT-11-0415","article-title":"The Bcl-2\/Bcl-X(L)\/Bcl-w inhibitor, navitoclax, enhances the activity of chemotherapeutic agents in\u00a0vitro and in\u00a0vivo","volume":"10","author":"Chen","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.celrep.2015.12.003_bib8","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nm.3832","article-title":"DOT1L inhibits SIRT1-mediated epigenetic silencing to maintain leukemic gene expression in MLL-rearranged leukemia","volume":"21","author":"Chen","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2015.12.003_bib9","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1158\/2159-8290.CD-14-0353","article-title":"Maturation stage of T-cell acute lymphoblastic leukemia determines BCL-2 versus BCL-XL dependence and sensitivity to ABT-199","volume":"4","author":"Chonghaile","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.celrep.2015.12.003_bib10","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature10509","article-title":"Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia","volume":"478","author":"Dawson","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2015.12.003_bib11","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1182\/blood-2007-06-098012","article-title":"BCL-2 dependence and ABT-737 sensitivity in acute lymphoblastic leukemia","volume":"111","author":"Del Gaizo Moore","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2015.12.003_bib12","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/pbc.25322","article-title":"Intensified chemotherapy without SCT in infant ALL: results from COG P9407 (cohort 3)","volume":"62","author":"Dreyer","year":"2015","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.celrep.2015.12.003_bib13","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature09883","article-title":"BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibition","volume":"473","author":"Duy","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2015.12.003_bib14","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1101\/gad.1741408","article-title":"Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemia","volume":"22","author":"Guenther","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.celrep.2015.12.003_bib15","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1124\/mol.109.060780","article-title":"The Bcl-2 homology domain 3 mimetic ABT-737 targets the apoptotic machinery in acute lymphoblastic leukemia resulting in synergistic in\u00a0vitro and in\u00a0vivo interactions with established drugs","volume":"77","author":"High","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.celrep.2015.12.003_bib16","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1182\/blood-2007-03-080325","article-title":"Activity of vincristine, L-ASP, and dexamethasone against acute lymphoblastic leukemia is enhanced by the BH3-mimetic ABT-737 in\u00a0vitro and in\u00a0vivo","volume":"110","author":"Kang","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2015.12.003_bib17","doi-asserted-by":"crossref","first-page":"5604","DOI":"10.1182\/blood-2011-04-348052","article-title":"Abnormal expression of FLI1 protein is an adverse prognostic factor in acute myeloid leukemia","volume":"118","author":"Kornblau","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2015.12.003_bib18","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ccr.2008.10.001","article-title":"H3K79 methylation profiles define murine and human MLL-AF4 leukemias","volume":"14","author":"Krivtsov","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2015.12.003_bib19","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.celrep.2015.04.004","article-title":"Degree of recruitment of DOT1L to MLL-AF9 defines level of H3K79 Di- and tri-methylation on target genes and transformation potential","volume":"11","author":"Kuntimaddi","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2015.12.003_bib20","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.str.2012.11.011","article-title":"Leukemia fusion target AF9 is an intrinsically disordered transcriptional regulator that recruits multiple partners via coupled folding and binding","volume":"21","author":"Leach","year":"2013","journal-title":"Structure"},{"key":"10.1016\/j.celrep.2015.12.003_bib21","doi-asserted-by":"crossref","first-page":"279ra40","DOI":"10.1126\/scitranslmed.aaa4642","article-title":"Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy","volume":"7","author":"Leverson","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2015.12.003_bib22","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.molcel.2010.01.026","article-title":"AFF4, a component of the ELL\/P-TEFb elongation complex and a shared subunit of MLL chimeras, can link transcription elongation to leukemia","volume":"37","author":"Lin","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.celrep.2015.12.003_bib23","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.celrep.2013.03.038","article-title":"MLL-ENL inhibits polycomb repressive complex 1 to achieve efficient transformation of hematopoietic cells","volume":"3","author":"Maethner","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2015.12.003_bib24","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.4161\/cc.8.16.9280","article-title":"FAS-associated factor 1 (FAF1): diverse functions and implications for oncogenesis","volume":"8","author":"Menges","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.celrep.2015.12.003_bib25","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/978-1-59745-418-6_21","article-title":"Chromatin immunoprecipitation (ChIP) for analysis of histone modifications and chromatin-associated proteins","volume":"538","author":"Milne","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.celrep.2015.12.003_bib26","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1101\/gad.1898410","article-title":"Linking H3K79 trimethylation to Wnt signaling through a novel Dot1-containing complex (DotCom)","volume":"24","author":"Mohan","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.celrep.2015.12.003_bib27","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1586\/17474086.2015.1029450","article-title":"Highlights in the treatment of chronic lymphocytic leukemia from the 2014 meeting of the American Society of Hematology","volume":"8","author":"Molica","year":"2015","journal-title":"Expert Rev. Hematol."},{"key":"10.1016\/j.celrep.2015.12.003_bib28","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1182\/blood-2007-05-090514","article-title":"A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification","volume":"110","author":"Mueller","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2015.12.003_bib29","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1158\/2159-8290.CD-13-0609","article-title":"Selective BCL-2 inhibition by ABT-199 causes on-target cell death in acute myeloid leukemia","volume":"4","author":"Pan","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.celrep.2015.12.003_bib30","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0140-6736(07)61126-X","article-title":"A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial","volume":"370","author":"Pieters","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.celrep.2015.12.003_bib31","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1365-2141.2008.07100.x","article-title":"Abundant anti-apoptotic BCL-2 is a molecular target in leukaemias with t(4;11) translocation","volume":"141","author":"Robinson","year":"2008","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.celrep.2015.12.003_bib32","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nm.3048","article-title":"ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets","volume":"19","author":"Souers","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2015.12.003_bib33","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.1158\/1078-0432.CCR-14-0259","article-title":"Cell and molecular determinants of in\u00a0vivo efficacy of the BH3 mimetic ABT-263 against pediatric acute lymphoblastic leukemia xenografts","volume":"20","author":"Suryani","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2015.12.003_bib34","doi-asserted-by":"crossref","first-page":"e33894","DOI":"10.1371\/journal.pone.0033894","article-title":"Pharmacokinetic modeling of an induction regimen for in\u00a0vivo combined testing of novel drugs against pediatric acute lymphoblastic leukemia xenografts","volume":"7","author":"Szymanska","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.celrep.2015.12.003_bib35","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1158\/1078-0432.CCR-10-2353","article-title":"Navitoclax enhances the efficacy of taxanes in non-small cell lung cancer models","volume":"17","author":"Tan","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2015.12.003_bib36","doi-asserted-by":"crossref","first-page":"e52798","DOI":"10.1371\/journal.pone.0052798","article-title":"In\u00a0vivo imaging enables high resolution preclinical trials on patients\u2019 leukemia cells growing in mice","volume":"7","author":"Terziyska","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.celrep.2015.12.003_bib37","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1182\/blood-2005-03-1283","article-title":"Targeting MLL-AF4 with short interfering RNAs inhibits clonogenicity and engraftment of t(4;11)-positive human leukemic cells","volume":"106","author":"Thomas","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2015.12.003_bib38","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1182\/blood-2012-04-425033","article-title":"Potent obatoclax cytotoxicity and activation of triple death mode killing across infant acute lymphoblastic leukemia","volume":"121","author":"Urtishak","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2015.12.003_bib39","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ccr.2013.06.002","article-title":"Targeting BCL-2 with the BH3 mimetic ABT-199 in estrogen receptor-positive breast cancer","volume":"24","author":"Vaillant","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2015.12.003_bib40","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1182\/blood-2013-01-475855","article-title":"ABT-199, a new Bcl-2-specific BH3\u00a0mimetic, has in\u00a0vivo efficacy against aggressive Myc-driven mouse\u00a0lymphomas without provoking thrombocytopenia","volume":"121","author":"Vandenberg","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2015.12.003_bib41","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.1074\/jbc.M112.422204","article-title":"Direct interaction of Bax and Bak proteins with Bcl-2 homology domain 3 (BH3)-only proteins in living cells revealed by fluorescence complementation","volume":"288","author":"Vela","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.celrep.2015.12.003_bib42","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature09779","article-title":"Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7","volume":"471","author":"Wertz","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2015.12.003_bib43","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.celrep.2012.12.016","article-title":"RUNX1 is a key target in t(4;11) leukemias that contributes to gene activation through an AF4-MLL complex interaction","volume":"3","author":"Wilkinson","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2015.12.003_bib44","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1158\/1535-7163.MCT-11-0693","article-title":"Navitoclax (ABT-263) reduces Bcl-x(L)-mediated chemoresistance in ovarian cancer models","volume":"11","author":"Wong","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.celrep.2015.12.003_bib45","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ccr.2009.12.040","article-title":"A higher-order complex containing AF4 and ENL family proteins with P-TEFb facilitates oncogenic and physiologic MLL-dependent transcription","volume":"17","author":"Yokoyama","year":"2010","journal-title":"Cancer Cell"}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124715014151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124715014151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:47:22Z","timestamp":1761904042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124715014151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":45,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S2211124715014151"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2015.12.003","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726044430.793512750","asserted-by":"object"}]},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MLL-Rearranged Acute Lymphoblastic Leukemias Activate BCL-2 through H3K79 Methylation and Are Sensitive to the BCL-2-Specific Antagonist ABT-199","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2015.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}